These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22814581)

  • 1. Gastric atrophy and oesophageal squamous cell carcinoma: possible interaction with dental health and oral hygiene habit.
    Nasrollahzadeh D; Malekzadeh R; Aghcheli K; Sotoudeh M; Merat S; Islami F; Kamangar F; Abnet CC; Shakeri R; Pourshams A; Semnani S; Boffetta P; Dawsey SM; Ye W
    Br J Cancer; 2012 Aug; 107(5):888-94. PubMed ID: 22814581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis.
    Nasrollahzadeh D; Aghcheli K; Sotoudeh M; Shakeri R; Persson EC; Islami F; Kamangar F; Abnet CC; Boffetta P; Engstrand L; Dawsey SM; Malekzadeh R; Ye W
    PLoS One; 2011; 6(10):e26957. PubMed ID: 22066020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohort.
    Ren JS; Kamangar F; Qiao YL; Taylor PR; Liang H; Dawsey SM; Liu B; Fan JH; Abnet CC
    Gut; 2009 May; 58(5):636-42. PubMed ID: 19136509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
    Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
    Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum pepsinogens and risk of esophageal squamous dysplasia.
    Kamangar F; Diaw L; Wei WQ; Abnet CC; Wang GQ; Roth MJ; Liu B; Lu N; Giffen C; Qiao YL; Dawsey SM
    Int J Cancer; 2009 Jan; 124(2):456-60. PubMed ID: 18844222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations Between Gastric Atrophy and Its Interaction With Poor Oral Health and the Risk for Esophageal Squamous Cell Carcinoma in a High-Risk Region of China: A Population-Based Case-Control Study.
    Ekheden I; Yang X; Chen H; Chen X; Yuan Z; Jin L; Lu M; Ye W
    Am J Epidemiol; 2020 Sep; 189(9):931-941. PubMed ID: 31899792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
    Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
    Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum gastrin and the pepsinogen I/II ratio as markers for diagnosis of premalignant gastric lesions.
    Shafaghi A; Mansour-Ghanaei F; Joukar F; Sharafkhah M; Mesbah A; Askari K; Geranmayeh S; Mehrvarz A; Souti F; Sokhanvar H; Fakhrieh S; Aminian K; Yousefi-Mashhour M; Khosh-Sorur M; Rasoulian J
    Asian Pac J Cancer Prev; 2013; 14(6):3931-6. PubMed ID: 23886209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern Iran.
    Nejadi-Kelarijani F; Roshandel G; Semnani S; Ahmadi A; Faghani B; Besharat S; Akhavan-Tabib A; Amiriani T
    Asian Pac J Cancer Prev; 2014; 15(17):7433-6. PubMed ID: 25227854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum ghrelin is inversely associated with risk of subsequent oesophageal squamous cell carcinoma.
    Murphy G; Kamangar F; Albanes D; Stanczyk FZ; Weinstein SJ; Taylor PR; Virtamo J; Abnet CC; Dawsey SM; Freedman ND
    Gut; 2012 Nov; 61(11):1533-7. PubMed ID: 22180062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pepsinogen and gastrin in the noninvasive diagnosis of gastric atrophy. A case-control study in Peruvian population].
    Colarossi A; Inga R; Prochazka R; Reyes U; Bussalleu A; Barúa RL
    Rev Gastroenterol Peru; 2011; 31(2):110-5. PubMed ID: 21836650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical utility of serum pepsinogen levels as a screening test of atrophic gastritis].
    Chae H; Lee JH; Lim J; Kim M; Kim Y; Han K; Kang CS; Shim SI; Kim JI; Park SH
    Korean J Lab Med; 2008 Jun; 28(3):201-6. PubMed ID: 18594172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric atrophy and risk of oesophageal cancer and gastric cardia adenocarcinoma--a systematic review and meta-analysis.
    Islami F; Sheikhattari P; Ren JS; Kamangar F
    Ann Oncol; 2011 Apr; 22(4):754-760. PubMed ID: 20860989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
    Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
    Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease of serum total ghrelin in extensive atrophic gastritis: comparison with pepsinogens in histological reference.
    Eun Bae S; Hoon Lee J; Soo Park Y; Ok Kim S; Young Choi J; Yong Ahn J; Hoon Kim D; Don Choi K; June Song H; Hyug Lee G; Choe J; Jin Jang S; Jung HY
    Scand J Gastroenterol; 2016; 51(2):137-44. PubMed ID: 26513345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum pepsinogens and Helicobacter pylori in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study.
    Cook MB; Dawsey SM; Diaw L; Blaser MJ; Perez-Perez GI; Abnet CC; Taylor PR; Albanes D; Virtamo J; Kamangar F
    Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):1966-75. PubMed ID: 20647397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potentialities of a serological method in diagnosis of atrophic gastritis].
    Pimenov SI; Makarenko EV
    Ter Arkh; 2008; 80(2):15-21. PubMed ID: 18372589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study.
    Storskrubb T; Aro P; Ronkainen J; Sipponen P; Nyhlin H; Talley NJ; Engstrand L; Stolte M; Vieth M; Walker M; Agréus L
    Scand J Gastroenterol; 2008; 43(12):1448-55. PubMed ID: 18663663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori infection and fundic gastric atrophy are not associated with esophageal squamous cell carcinoma: a case-control study.
    Venerito M; Kohrs S; Wex T; Adolf D; Kuester D; Schubert D; Peitz U; Mönkemüller K; Malfertheiner P
    Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):859-64. PubMed ID: 21811162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.